An Open-Label, Multi-Center, Global Study to Evaluate Long Term Safety and Efficacy in Patients Who are Receiving or Who Previously Received Durvalumab in Other Protocols (WAVE)

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date23/03/20 → 22/03/25

Keywords

  • clinical trial
  • treatment safety
  • treatment efficacy